Market Tracker

09/03 10:37am ET

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

19.75
Delayed Data
As of Sep 02
 +0.92 / +4.89%
Today’s Change
7.31
Today|||52-Week Range
23.30
+137.95%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close18.83
Today’s open19.05
Day’s range18.23 - 19.77
Volume1,070,105
Average volume (3 months)1,139,524
Market cap$912.2M
Dividend yield--
Data as of 09/02/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-52.08%
Earnings growth (next 5 years)+94.00%
Revenue growth (last year)+915.43%
P/E ratio30.1
Price/Sales3.44
Price/Book11.34

Competitors

 Today’s
change
Today’s
% change
PDLIPDL BioPharma Inc-0.17-3.05%
FLMLFlamel Technologies ...+0.91+4.14%
MGNXMacroGenics Inc+0.91+3.53%
RPTPRaptor Pharmaceutica...+1.33+11.40%
Data as of 09/02/2015

Financials

Next reporting dateNovember 10, 2015
EPS forecast (this quarter)$0.03
Annual revenue (last year)$122.0M
Annual profit (last year)$19.9M
Net profit margin16.28%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts